Safety of Subcutaneous Piperacillin/Tazobactam Administration Compared to Intravenous Administration: Propensity Score-Matched Cohort Study

J Am Med Dir Assoc. 2020 Jan;21(1):127-128. doi: 10.1016/j.jamda.2019.08.010. Epub 2019 Oct 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Intravenous
  • Anti-Bacterial Agents* / adverse effects
  • Cohort Studies
  • Drug Therapy, Combination
  • Humans
  • Penicillanic Acid / adverse effects
  • Piperacillin* / adverse effects
  • Piperacillin, Tazobactam Drug Combination / adverse effects
  • Propensity Score

Substances

  • Anti-Bacterial Agents
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Piperacillin